Click Here to return To Results

 

Interferon beta for Secondary Progressive Multiple Sclerosis: A Systematic Review JNNP 84:420-426, La Mantia, L.,et al, 2013 See this aricle in Pubmed Article Abstract 3 year treatment with IFN? does not delay permanent disability in SPMS but reduces relapse risk, indicating that the anti-inflammatory effect of IFN? is unable to prevent MS progression once it has become established.

Related Tags

(click to filter results - removes previous filter) efficacy interferon interferon beta 1-a interferon beta 1-b multiple sclerosis multiple sclerosis,relapsing multiple sclerosis,secondary progressive multiple sclerosis,treatment of prognosis quality of life treatment of neurologic disorder

Click Here to return To Results